MET fusions are targetable genomic variants in the treatment of advanced malignancies.

导出 OA

翻译打印收藏纠错

作者： Dantong,Sun ^[1] ; Xiaoming,Xing ^[2] ; Yongjie,Wang ^[3] ; Helei,Hou ^[4]

作者单位： Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. ^[1] State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. ^[2] Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China. ^[3] Department of Thoracic Surgery, The Affiliation Hospital of Qingdao University, No. 59 Haier Road, Qingdao, 266000, Shandong, China. ^[4] Department of Oncology, The Affiliated Hospital of Qingdao University, No. 7 Jiaxing Road, Qingdao, 266000, Shandong, China. houheleihhl@163.com. ^[5]

关键词 Cancer MET fusions MET-TKIs Targeted therapy

主题词人类(Humans);肿瘤(Neoplasms);细胞增殖(Cell Proliferation);基因组学(Genomics);突变(Mutation)

DOI 10.1186/s12964-023-01454-0

PMID 38195556

发布时间 2024-01-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交